A Search Service for Abbreviation / Long Form

■ Search Result - Abbreviation : mut

Search Conditions:
Search Keyword : mut
Search Method : Exact match.
Research Area:

Results:  
Hit abbr.: 3 kinds.
(Click one to see its hit entries.)

(Appearance freq, Descending)
Abbreviation: mut
Appearance Frequency: 185 time(s)
Long forms: 39

Display Settings:
[Entries Per Page]
 per page
Page Control
Page: of
Long Form No. Long Form Research Area Co-occurring Abbreviation PubMed/MEDLINE Info. (Year, Title)
mutant
(92 times)
Neoplasms
(20 times)
WT (66 times)
PFS (4 times)
ROS (3 times)
1993 Immunohistochemical expression of mutant p53 oncogene in transitional mucosa adjacent to human colon cancer.
mutated
(28 times)
Neoplasms
(13 times)
WT (19 times)
OS (5 times)
CI (2 times)
1996 Dihydrorhodamine 123 identifies impaired mitochondrial respiratory chain function in cultured cells harboring mitochondrial DNA mutations.
mutation
(15 times)
Neoplasms
(7 times)
WT (7 times)
FU (2 times)
IDH (2 times)
1997 beta-MHC transgene expression in suspended and mechanically overloaded/suspended soleus muscle of transgenic mice.
mutations
(12 times)
Neoplasms
(8 times)
OS (4 times)
AML (2 times)
EFS (2 times)
2003 Prevalence of BRCA1 and BRCA2 germline mutations in young breast cancer patients: a population-based study.
BRAF-mutated
(2 times)
Neoplasms
(2 times)
CIMP (1 time)
CRC (1 time)
mCRC (1 time)
2018 Single-Agent Regorafenib in Metastatic Colorectal Cancer Patients with Any RAS or BRAF Mutation Previously Treated with FOLFOXIRI plus Bevacizumab (PREVIUM Trial).
IDH-mutant
(2 times)
Neoplasms
(1 time)
wt (2 times)
ADC (1 time)
GBM (1 time)
2017 Correlation of immune phenotype with IDH mutation in diffuse glioma.
mutator
(2 times)
Neoplasms
(1 time)
GPI (1 time)
PIGA (1 time)
2001 Glycophosphatidylinositol-anchored protein deficiency as a marker of mutator phenotypes in cancer.
2-mutations, p
(1 time)
Neoplasms
(1 time)
life (1 time)
2007 Evaluation of mathematical models for breast cancer risk assessment in routine clinical use.
Clock-mutant
(1 time)
Vascular Diseases
(1 time)
ACh (1 time)
eNOS (1 time)
LC (1 time)
2016 Differential Regulation of BMAL1, CLOCK, and Endothelial Signaling in the Aortic Arch and Ligated Common Carotid Artery.
10  Manipulating Nef
(1 time)
Molecular Biology
(1 time)
--- 2016 Incorporation of Heterologous Proteins in Engineered Exosomes.
11  markedly decreased drug-sensitivity of KIT
(1 time)
Hematology
(1 time)
AML (1 time)
TKI (1 time)
2014 Transitory dasatinib-resistant states in KIT(mut) t(8;21) acute myeloid leukemia cells correlate with altered KIT expression.
12  may be affected by the presence of synonymous AIP
(1 time)
Endocrinology
(1 time)
--- 2015 Prevalence of AIP mutations in a series of Turkish acromegalic patients: are synonymous AIP mutations relevant?
13  MED12-mutant
(1 time)
Reproductive Medicine
(1 time)
MED12 (1 time)
mTOR (1 time)
UFs (1 time)
2020 Introduction of Somatic Mutation in MED12 Induces Wnt4/beta-Catenin and Disrupts Autophagy in Human Uterine Myometrial Cell.
14  median age at uterine fibroid diagnosis for FH
(1 time)
Dermatology
(1 time)
CI (1 time)
FH (1 time)
HLRCC (1 time)
2008 Association of germline mutations in the fumarate hydratase gene and uterine fibroids in women with hereditary leiomyomatosis and renal cell cancer.
15  MENDEL are useful tools for calculating p
(1 time)
Neoplasms
(1 time)
life (1 time)
2007 Evaluation of mathematical models for breast cancer risk assessment in routine clinical use.
16  mice immunized with Nef
(1 time)
Virology
(1 time)
--- 2009 Anti-tumor CD8+ T cell immunity elicited by HIV-1-based virus-like particles incorporating HPV-16 E7 protein.
17  mitochondria clustering and ROS production were dramatically reduced in Actin
(1 time)
Cell Biology
(1 time)
ROS (1 time)
TNF (1 time)
2004 Beta-actin is required for mitochondria clustering and ROS generation in TNF-induced, caspase-independent cell death.
18  MK-2206 promotes ARF nucleolar localization, reduced p53
(1 time)
Neoplasms
(1 time)
NPM (1 time)
2014 AKT regulates NPM dependent ARF localization and p53mut stability in tumors.
19  model of human CN-AML with FLT3-ITD
(1 time)
Medicine
(1 time)
CN-AML (1 time)
2013 Establishment of xenotransplantation model of human CN-AML with FLT3-ITD (mut) /NPM1 (-) in NOD/SCID mice.
20  model of human FLT3-ITD
(1 time)
Medicine
(1 time)
CN-AML (1 time)
2013 Establishment of xenotransplantation model of human CN-AML with FLT3-ITD (mut) /NPM1 (-) in NOD/SCID mice.
21  most of the expected crosspeaks were observed for the unliganded
(1 time)
Biochemistry
(1 time)
sCD4 (1 time)
2014 NMR observation of HIV-1 gp120 conformational flexibility resulting from V3 truncation.
22  motif resulted in Vac(++) DeltaD/D
(1 time)
Microbiology
(1 time)
--- 2001 A p-loop motif and two basic regions in the regulatory protein GvpD are important for the repression of gas vesicle formation in the archaeon Haloferax mediterranei.
23  mouse cortical neurons revealed aggregation of alpha-II
(1 time)
Genetics, Medical
(1 time)
AIS (1 time)
WT (1 time)
2010 Dominant-negative mutations in alpha-II spectrin cause West syndrome with severe cerebral hypomyelination, spastic quadriplegia, and developmental delay.
24  multivariate analyses, the BRCA
(1 time)
Transplantation
(1 time)
CI (1 time)
HDC AHSCT (1 time)
HR (1 time)
2016 Highly favorable outcome in BRCA-mutated metastatic breast cancer patients receiving high-dose chemotherapy and autologous hematopoietic stem cell transplantation.
25  multivariate analysis of N/F
(1 time)
Neoplasms
(1 time)
ABD (1 time)
T-ALL (1 time)
T-LBL (1 time)
2012 Clinical impact of NOTCH1 and/or FBXW7 mutations, FLASH deletion, and TCR status in pediatric T-cell lymphoblastic lymphoma.
26  mutant form, r
(1 time)
Biochemistry
(1 time)
BvTI (1 time)
2005 Cloning, expression and characterization of Bauhinia variegata trypsin inhibitor BvTI.
27  mutant line Actin
(1 time)
Cell Biology
(1 time)
ROS (1 time)
TNF (1 time)
2004 Beta-actin is required for mitochondria clustering and ROS generation in TNF-induced, caspase-independent cell death.
28  mutant of the HIV-1 Nef protein referred to as Nef
(1 time)
Molecular Biology
(1 time)
--- 2016 Incorporation of Heterologous Proteins in Engineered Exosomes.
29  mutant of the HIV-1 Nef protein, Nef
(1 time)
Allergy and Immunology
(1 time)
VLPs (1 time)
2012 A strategy of antigen incorporation into exosomes: comparing cross-presentation levels of antigens delivered by engineered exosomes and by lentiviral virus-like particles.
30  mutant version, Dz-104
(1 time)
Genetics, Medical
(1 time)
5'UTR (1 time)
EGFP (1 time)
FACS (1 time)
2007 An efficient RNA-cleaving DNA enzyme can specifically target the 5'-untranslated region of severe acute respiratory syndrome associated coronavirus (SARS-CoV).
31  mutant-type
(1 time)
Pharmacology
(1 time)
BMI1 (1 time)
miR-132 (1 time)
NC (1 time)
2019 MicroRNA-132 reverses cisplatin resistance and metastasis in ovarian cancer by the targeted regulation on Bmi-1.
32  mutase apoenzyme
(1 time)
Medicine
(1 time)
--- 1991 Differential diagnosis of mut and cbl methylmalonic aciduria by DNA-mediated gene transfer in primary fibroblasts.
33  mutated form
(1 time)
Neoplasms
(1 time)
MMTV (1 time)
WT (1 time)
1994 Negative effects of wild-type p53 and s-Myc on cellular growth and tumorigenicity of glioma cells. Implication of the tumor suppressor genes for gene therapy.
34  mutation gene
(1 time)
Microbiology
(1 time)
RT (1 time)
2001 HIV-1 multi-dideoxynucleoside resistance mutation (Q151M): prevalence, associated resistance mutations and response to antiretroviral salvage treatment.
35  mutation, and the resulting GvpD
(1 time)
Microbiology
(1 time)
--- 2001 A p-loop motif and two basic regions in the regulatory protein GvpD are important for the repression of gas vesicle formation in the archaeon Haloferax mediterranei.
36  mutually exclusive with IDH
(1 time)
Neoplasms
(1 time)
AML (1 time)
TET2 (1 time)
2012 TET2 mutations in acute myeloid leukemia (AML): results from a comprehensive genetic and clinical analysis of the AML study group.
37  myelomonocytic leukemia, CBL
(1 time)
Hematology
(1 time)
--- 2012 Use of CBL exon 8 and 9 mutations in diagnosis of myeloproliferative neoplasms and myelodysplastic/myeloproliferative disorders: an analysis of 636 cases.
38  NPM1-mutated
(1 time)
Hematology
(1 time)
AML (1 time)
BPDCN (1 time)
CN-AML (1 time)
2020 Prognostic relevance of a blastic plasmacytoid dendritic cell neoplasm-like immunophenotype in cytogenetically normal acute myeloid leukemia patients.
39  S190-mediated immunodominance also operated in 1.4HBV-S
(1 time)
Allergy and Immunology
(1 time)
HBV (1 time)
rSPs (1 time)
Tg (1 time)
2014 Differential presentation of endogenous and exogenous hepatitis B surface antigens influences priming of CD8(+) T cells in an epitope-specific manner.